MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Evaluation of CSF cytokine profiles in people with Parkinson disease and age-matched controls.

    G. Crotty, D. Vaughan, G. Moloney, G. O'Keeffe, S. O'Sullivan, A. Sullivan (Cork, Ireland)

    Objective: To investigate the levels of cytokines in the cerebrospinal fluid of subjects with Parkinson disease (PD) and matched healthy controls. Background: Neuroinflammation is thought…
  • 2017 International Congress

    Saccadic impairment in patients with Gaucher’s disease type 3

    J. Blume, C. Kämpe Björkvall, M. Machaczka, P. Svenningsson (Stockholm, Sweden)

    Objective: To characterize saccades in patients with chronic neuronopathic Gaucher’s disease (GD3) in relationship to their neurological and cognitive status using a computer-based eye-tracking technique.  Background: GD3 is…
  • 2017 International Congress

    A Pair of Brothers with Aceruloplasminemia Due to a Novel Nonsense Mutation: Unusual Phenotype and Neurological Improvement After Iron-Chelation Therapy with Deferasirox.

    F. Valzania, F. Cavallieri, M. Fiorini, S. Contardi, F. Ferrara, E. Menozzi, S. Scarlini, F. Cavalleri, M. Molinari, A. Pietrangelo, E. Corradini (Modena, Italy)

    Objective: We describe the phenotype of a novel ceruloplasmin mutation and the neurological response to different iron-chelating therapies. Background: Aceruloplasminemia (AC) is a rare autosomal…
  • 2017 International Congress

    Gait, Freezing of Gait and Falls detection using wearable sensors; a systematic review

    A.L. Silvade Lima, L.JW. Evers, T. Hahn, L. Bataille, J.L. Hamilton, M.A. Little, B.R. Bloem, M.J. Faber (Nijmegen, Netherlands)

    Objective: An overview of the use of wearable systems to assess gait, freezing of gait (FOG) and falls in patients with Parkinson’s disease (PD).  Background:…
  • 2017 International Congress

    Wearable sensor-based therapy titration for Parkinson’s Disease

    R. Schmidt, D. Heldman, A. Hadley, D. Riley (Cleveland, OH, USA)

    Objective: To describe a home-based method for improved Parkinson’s therapy titration. Background: Many patients with Parkinson’s disease, due to the location of their residence or…
  • 2017 International Congress

    Personal KinetiGraph Devices Assessing Efficacy of Continuous Enteral Carbidopa/Levodopa Infusion Therapy

    J. Margolesky, C. Luca (Miami, FL, USA)

    Objective: To assess the utility of Personal KinetiGraph (PKG) devices to objectively quantify difference in motor symptoms and motor fluctuations before and after the initiation…
  • 2017 International Congress

    Parkinson’s Disease Medications Availability in Each Philippine Region

    S. Villaraza, C. Go (Manila, Philippines)

    Objective: This study aimed to enumerate the different Parkinson’s disease medications in the Philippines and describe the distribution and availability among the 17 regions of…
  • 2017 International Congress

    Managing severe dyskinesia in Parkinson’s Disease using 24-hour Levodopa/Carbidopa Intestinal Gel Infusion

    B. Cruse, D. Tsui, J. Griffith, H. Morales-Briceno, F. Chang, A. Ha, S. Kim, N. Wolfe, V. Kwan, N. Mahant, V. Fung (Westmead, Australia)

    Objective: We report the effective treatment of troublesome dyskinesias in Parkinson’s disease (PD), unresponsive to 16-hour daytime infusions, using 24-hour Levodopa/Carbidopa Intestinal Gel (LCIG). Background:…
  • 2017 International Congress

    A model community neurofitness and wellness center for people with Parkinson disease. 1-year group pilot data

    E. Borchers, B. Farley, D. Snider, T. McIsaac, J. Bazan-Wigle (Tucson, AZ, USA)

    Objective: Report preliminary one-year benefits of ongoing research-based community group exercise programs integrated with 6-month therapy coaching for people of varying disease severity (to date,…
  • 2017 International Congress

    Inferring the presence of Parkinsonian rest tremor from subthalamic local field potential recordings

    J. Hirschmann, J.-M. Schoffelen, A. Schnitzler, M. van Gerven (Düsseldorf, Germany)

    Objective: To investigate the possibility of tremor detection based on deep brain recordings. Background: Electrophysiological studies have revealed associations between neuronal oscillations in the subthalamic…
  • « Previous Page
  • 1
  • …
  • 132
  • 133
  • 134
  • 135
  • 136
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley